This evidence could indicate that chemotherapy delivered at radiosensitizing doses has some systemic spatial cooperative effect, or that the improved local control of chemoradiotherapy decreases ...
What adverse events did you observe? Dahl: We found that the chemotherapy used at radiosensitizing doses in trimodality strategies is generally well-tolerated, even in fairly frail patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback